Bevemipretide

N/A

Report date: 2024/05/09 14:44:49

Base Information

Drug NameBevemipretide
Drug Alias NameSmall molecule that targets the cardiolipin-rich inner mitochondrial membrane (Stealth Biotherapeutics)SBT-272
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionATPase stimulantsReactive oxygen species inhibitors
TargetsATPaseReactive oxygen species
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStealth Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStealth Biotherapeutics
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A